21-01-2025
Nothing from the bears on how the valuation looks if next years estimates are cut quite aggressively?
Takeover potential on an EV/EBITDA basis?
Or wait until they warn to buy?
10-11-2024
You may well be right who knows ? But as I say it's become too risky for me. However , in the event that 2025 forecast revenues are lowered , and the sp materially drops then I will be buying back in as I believe they would become an immediate takeover target.. Interesting two months coming up..
19-09-2024
Shares Magazine write up.
hVIVO is in pole position to capitalise on increasing interest in human challenge trials
The contract research organisation sector has seen increasing M&A activity in recent years with average takeover premiums of around 30%
hxxps://www.sharesmagazine.co.uk/article/hvivo-is-in-pole-position-to-capitalise-on-increasing-interest-in-human-challenge-trials